Biocept Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St rises as Anthropic's IPO filing sharpens focus on AI trade
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Brazilās Lula wins historic fourth term, Flavio Bolsonaro refuses to concede
- Borr Drilling rig sinks off Gabon, one person dead and four missing
- Britain will not join Canada-led defence bank initiativeĀ
- CAE agrees to sell Flightscape unit to SITA for $500 million
- Stocks, bonds edge up ahead of 'formidable' week for risk
Biocept (BIOC) Reports Q3 Loss of $2.42/Share
November 13, 2018 4:11 PM ESTBiocept (NASDAQ: BIOC) reported Q3 EPS of ($2.42), versus ($5.90) reported last year. Revenue for the quarter came in at $762 thousand, versus $1.1 million reported last year.
For earnings history and earnings-related data on Biocept (BIOC) click here.
... More


